| 30 Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota.
29 Like citrate, the molecule hydroxycitrate is shown to inhibit growth of the crystal that is the principal component of kidney stones, suggesting that hydroxycitrate could be another treatment for kidney stone disease.
28 Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury.
27 PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection.
26 Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury.
25 Belatacept and Long-Term Outcomes in Kidney Transplantation.
24 Soluble Urokinase Receptor and Chronic Kidney Disease.
23 Urine excretion strategy for stem cell-generated embryonic kidneys.
22 Gestational Hypertension and Preeclampsia in Living Kidney Donors.
21 Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors.
20 EbpA vaccine antibodies block binding of Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice.
19 Association of Urinary Sodium and Potassium Excretion with Blood Pressure.
18 Increased gene copy number of VAMP7 disrupts human male urogenital development through altered estrogen action.
17 APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease.
16 Abatacept in B7-1–Positive Proteinuric Kidney Disease.
15 Mistargeting of Peroxisomal EHHADH and Inherited Renal Fanconi's Syndrome.
14 Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome.
13 Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy.
12 Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes.
11 An electronic interface for recording and stimulating nerves that innervate the bladder helps to restore normal bladder function in rats with spinal cord injury.